Designating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.
Summary
House Resolution 158 designates May 2025 as "Preeclampsia Awareness Month" in Pennsylvania. The resolution explains that preeclampsia is a serious pregnancy complication involving high blood pressure that can lead to seizures, stroke, organ failure, premature birth, and death of the mother or infant. It also highlights related conditions such as HELLP syndrome and eclampsia, and notes that public education about warning signs and symptoms can help pregnant individuals seek timely care.
The resolution is primarily commemorative and educational rather than regulatory. It does not create new duties, penalties, or program requirements in state law; instead, it expresses the House’s support for awareness efforts and for the Preeclampsia Foundation’s work to improve health care practices and support affected individuals. Its practical effect is to encourage outreach, prenatal education, and public recognition of maternal health risks during the designated month.
Impact
HR158 does not amend the Pennsylvania Consolidated Statutes or impose new legal obligations. Its impact is symbolic and promotional: it formally recognizes May 2025 as Preeclampsia Awareness Month and may be used by state agencies, health organizations, hospitals, and advocacy groups to support educational campaigns about pregnancy-related hypertensive disorders. The resolution may indirectly influence public health messaging, prenatal care awareness, and maternal health advocacy, but it leaves existing health-care law unchanged.
Sentiment
The available legislative history suggests broad support and little opposition. The House Health Committee reported the resolution as committed on a 26-0 vote, indicating unanimous committee approval. The bill text itself is framed in strongly supportive terms, emphasizing the seriousness of preeclampsia and the value of awareness, education, and advocacy. No committee transcript or recorded floor debate was provided showing dissent or controversy.
Contention
There is no notable recorded contention in the provided materials. Because the resolution is a nonbinding awareness designation, it appears to have been noncontroversial. Any discussion would likely center on maternal health awareness, the role of public education, and support for organizations like the Preeclampsia Foundation, rather than on policy disputes or legal changes.
Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.
Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.